CD84/SLAMF5 Antibody (273508) [Alexa Fluor® 488]

• Reactivity: Hu
• Applications: WB
• Clone: 273508
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Alexa Fluor 488

CD84/SLAMF5 Antibody (273508) [Alexa Fluor® 488] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human CD84/SLAMF5
  Lys22-Arg220
  Accession # Q9UIB8.1
• Specificity: Detects human CD84/SLAMF5 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross‑reactivity with recombinant mouse CD84 is observed.
• Source: N/A
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for CD84/SLAMF5 Antibody (273508) [Alexa Fluor® 488]

• CD84 antigen (leukocyte antigen)
• CD84 antigen
• CD84 molecule
• CD84
• Cell surface antigen MAX.3
• DKFZp781E2378
• hCD84
• hly9-beta
• leucocyte differentiation antigen CD84
• leukocyte antigen CD84
• Leukocyte differentiation antigen CD84
• Ly-9B
• mCD84
• Signaling lymphocytic activation molecule 5
• SLAM family member 5
• SLAMF5
• SLAMF5LY9B

Background

The CD2 family receptors are type I transmembrane glycosylated proteins belonging to the immunoglobulin (Ig) superfamily. They are characterized by an extracellular region containing an N-terminal variable (V) Ig domain lacking disulfide bonds and a truncated Ig constant 2 (C2) domain with two disulfide bonds (1). CD84, also known as Ly-9B, is a member of the CD150/SLAM (signaling lymphocyte activation molecule) subfamily of the CD2 family and is designated SLAMF5 (2). The SLAM family, comprising at least nine members, is defined by the presence of at least two immunoreceptor tyrosine-based switch motifs (ITSM) in the intracellular region. The ITSM motifs interact with the SH2 (Src homology 2) domain of cytoplasmic adaptor molecules SAP (SLAM-associated protein) and EAT-2 (EWS/FliI-activated transcript 2) to transduce SLAM family receptor-mediated signals (2). SLAM family receptors are thought to mediate cell adhesion in the immune synapse between T cells and antigen-presenting cells to modulate immune responses. Human CD84 cDNA encodes a 328 amino acid residue (aa) precursor protein with a 21 aa signal peptide and a 199 aa extracelllular domain (3). It is expressed on B and T cells, monocytes and platelets (3, 4). CD84 is a self-ligand. The homotypic CD84-CD84 interaction requires only the first N-terminal Ig V domai (4). In T cells, CD84 has been found to act as a co-stimulatory molecule, enhancing anti-CD3 induced IFN-gamma production in lymphocytes and increasing anti-CD3 induced proliferation in PHA T cells blasts (4, 5). In B cells, CD84 is differentially expressed, with the CD84^hi B cells representing a subset of memory B cells (6). While ligation of CD84 in the memory B cells leads to the recruitment of SAP and EAT-2 the exact role CD84 has in memory B cell functions remains to be determined.The exact role played by CD84 in B cells functions remains to be determined. Human and mouse CD84 share approximately 57% aa sequence identity.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Uniprot:
  • Q9UIB8.1()